Stage IV Squamous Cell Lung Carcinoma AJCC v7 Recruiting Phase 2 / 3 Trials for Ipilimumab (DB06186)

IndicationStatusPhase
DBCOND0092102 (Stage IV Squamous Cell Lung Carcinoma AJCC v7)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs